We are live on ! Find out more
ML

McAdam LLC Portfolio holdings

AUM $2.22B
1-Year Est. Return 16.98%
This Fund
S&P 500
This Quarter Est. Return
-1.28%
1 Year Est. Return
+16.98%
3 Year Est. Return
+46.26%
5 Year Est. Return
+42.13%
10 Year Est. Return
AUM
$218M
AUM Growth
+$76.2M
Cap. Flow
+$76.9M
Cap. Flow %
35.3%
Top 10 Hldgs %
64.33%
Holding
837
New
784
Increased
36
Reduced
8
Closed
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AET
226
DELISTED
Aetna Inc
AET
$23K 0.01%
+139
New +$25K
AMAT icon
227
Applied Materials
AMAT
$424B
$22K 0.01%
+389
New +$21.7K
HST icon
228
Host Hotels & Resorts
HST
$16.1B
$22K 0.01%
+1,207
New +$23.6K
MET icon
229
MetLife
MET
$60.9B
$22K 0.01%
+469
New +$22.8K
USB icon
230
US Bancorp
USB
$100B
$22K 0.01%
+439
New +$24K
USIG icon
231
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.5B
$22K 0.01%
+400
New +$21.9K
BIV icon
232
Vanguard Intermediate-Term Bond ETF
BIV
$29.1B
$21K 0.01%
+259
New +$21.2K
DFE icon
233
WisdomTree Europe SmallCap Dividend Fund
DFE
$163M
$21K 0.01%
+300
New +$21.5K
EMB icon
234
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.6B
$21K 0.01%
+190
New +$21.6K
IGV icon
235
iShares Expanded Tech-Software Sector ETF
IGV
$13.9B
$21K 0.01%
+630
New +$21.3K
NEE icon
236
NextEra Energy
NEE
$188B
$21K 0.01%
+512
New +$19.7K
SPHB icon
237
Invesco S&P 500 High Beta ETF
SPHB
$972M
$21K 0.01%
+492
New +$21.6K
TSN icon
238
Tyson Foods
TSN
$20.6B
$21K 0.01%
+290
New +$22.1K
EGRX
239
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$21K 0.01%
+400
New +$23.3K
BMY icon
240
Bristol-Myers Squibb
BMY
$126B
$20K 0.01%
+313
New +$20.1K
BTI icon
241
British American Tobacco
BTI
$136B
$20K 0.01%
+349
New +$21.9K
FMC icon
242
FMC
FMC
$1.43B
$20K 0.01%
+294
New +$21.9K
HUM icon
243
Humana
HUM
$47.7B
$20K 0.01%
+76
New +$20.6K
IGSB icon
244
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
$20K 0.01%
+390
New +$20.3K
SHW icon
245
Sherwin-Williams
SHW
$83.5B
$20K 0.01%
+150
New +$20.4K
UPS icon
246
United Parcel Service
UPS
$99.5B
$20K 0.01%
+190
New +$22K
VAC icon
247
Marriott Vacations Worldwide
VAC
$3.44B
$20K 0.01%
+150
New +$21.2K
ENB icon
248
Enbridge
ENB
$124B
$19K 0.01%
+606
New +$21.2K
MS icon
249
Morgan Stanley
MS
$339B
$19K 0.01%
+350
New +$19.4K
NGG icon
250
National Grid
NGG
$84.1B
$19K 0.01%
+371
New +$18.1K

Similar funds

McAdam LLC's Q1 2018 Portfolio in Review

As of Q1 2018, McAdam LLC held 837 positions worth $218M, up 54% from $142M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

McAdam LLC deployed $76.9M of net new capital in Q1 2018, opening 784 new positions and adding to 36 existing holdings. Its largest new stake was Celgene Corp: 6,617 shares worth $590K.

By sector, the portfolio is most concentrated in Technology at 1.4% of assets, up from 0.41% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Walgreens Boots Alliance, an estimated $207K trimmed.

  • McAdam LLC's largest Q1 2018 buy was Celgene Corp: 6,617 shares worth $590K.
  • McAdam LLC added most to Schwab Fundamental US Large Company Index ETF in Q1 2018, an estimated $5.5M increase.
  • McAdam LLC's biggest Q1 2018 reduction was Walgreens Boots Alliance, cutting an estimated $207K.
  • McAdam LLC's ten largest holdings make up 64% of its $218M portfolio in Q1 2018.
  • McAdam LLC opened 784 new positions and closed 0 in Q1 2018.
  • McAdam LLC's portfolio value rose 54% quarter-over-quarter to $218M.

Based on McAdam LLC's 13F filing for Q1 2018, filed 24 Apr 2018.